Klin Farmakol Farm. 2024;38(1):26-30 | DOI: 10.36290/far.2024.003

Adherence to therapy in chronic pulmonary diseases with a focus on COPD

Martin Poruba
Ústav farmakologie, Lékařská fakulta, Univerzita Palackého v Olomouci

Chronic obstructive pulmonary disease is one of the most significant causes of morbidity and mortality worldwide. Proper use of medicine is the mainstay in COPD pharmacotherapy. According to the studies, there is a lack of adherence to therapy for chronic diseases. One of the relevant reasons for poor adherence and treatment failure could be difficulty in drug administration. This review is focused on published literature on methods of checking adherence and also studies focused on adherence and proper handling of COPD medication.

Keywords: adherence, COPD, inhalation technic.

Accepted: March 26, 2024; Published: April 8, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Poruba M. Adherence to therapy in chronic pulmonary diseases with a focus on COPD. Klin Farmakol Farm. 2024;38(1):26-30. doi: 10.36290/far.2024.003.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ahmad FB, Anderson RN. The Leading Causes of Death in the US for 2020. JAMA. 2021;325(18):1829-1830. Go to original source... Go to PubMed...
    2. Pauk N. Léčba CHOPN. Klin Farmakol Farm. 2018;32(4):15-20 Go to original source...
    3. Implementační manuál pro program časného záchytu chronické obstrukční plicní nemoci v rizikové populaci: plán realizace a metodika. ÚZIS 2022. Available from https://nsc.uzis.cz/zdraveplice/res/file/dokumenty/implementacni-manual-plan-realizace-a-metodika.pdf.
    4. Vytřísalová M. Adherence k medikamentózní léčbě - známá neznámá. Remedia 2009; 20.
    5. Gandhi M, Murnane PM, Bacchetti P, et al. Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen. AIDS. 2017;31(16):2245-2251. Go to original source... Go to PubMed...
    6. Ritscher S, Hoyer M, Wunder C, et al. Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers - drug classes with low adherence in antihypertensive therapy. Sci Rep. 2019;9(1):15652. Go to original source... Go to PubMed...
    7. Kristiansen O, Vethe NT, Fagerland MW, et al. A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease. Br J Clin Pharmacol. 2019;85(12):2878-2885. Go to original source... Go to PubMed...
    8. Pilkova A, Sima M, Hartinger JM, et al. Novel approach to adherence assessment based on parent drug and metabolite pharmacokinetics: pilot study with spironolactone. Biomed Pap. 2022;10.5507/bp.2022.048. Go to original source... Go to PubMed...
    9. Garfield S, Clifford S, Eliasson L, et al. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11:149. Go to original source... Go to PubMed...
    10. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74. Go to original source... Go to PubMed...
    11. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209. Go to original source... Go to PubMed...
    12. George M, Topaz M, Rand C, et al. Inhaled corticosteroid beliefs, complementary and alternative medicine, and uncontrolled asthma in urban minority adults. J Allergy Clin Immunol. 2014;134(6):1252-1259. Go to original source... Go to PubMed...
    13. Bender BG. Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next? Curr Opin Pulm Med. 2014;20(2):132-137. Go to original source... Go to PubMed...
    14. Vytrisalova M, Hendrychova T, Touskova T, et al. Breathing Out Completely Before Inhalation: The Most Problematic Step in Application Technique in Patients With Non-Mild Chronic Obstructive Pulmonary Disease. Front Pharmacol. 2019;10:241. Go to original source... Go to PubMed...
    15. American Thoracic Society. Using Your Metered Dose inhaler, Patient Information series. Am J Respir Crit Care Med. 2014;190:5-6. Go to original source... Go to PubMed...
    16. Bartolo K, Balzan M, Schembri EL, et al. Predictors of correct technique in patients using pressurized metered dose inhalers. BMC Pulm Med. 2017;17(1):47. Go to original source... Go to PubMed...
    17. Dudvarski IA, Zugic V, Zvezdin B, et al. Influence of inhaler technique on asthma and COPD control: a multicenter experience. Int J Chron Obstruct Pulmon Dis. 2016;11:2509-2517. Go to original source... Go to PubMed...
    18. Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med. 2011;105(12):1815-1822. Go to original source... Go to PubMed...
    19. Hendrychova T, Svoboda M, Maly J, et al. Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population. Front Pharmacol. 2022;13:860270. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.